14-GI-93-NLG (NLG 0505) HyperAcute vaccine for locally advanced pancreatic cancer

Grants and Contracts Details

StatusFinished
Effective start/end date1/21/157/31/17

Funding

  • NewLink Genetics: $121,454.00